
Evonik will not enter takeover negotiations, though it is willing to hear BASF’s reasoning in a confidential, informational exchange.
Evonik’s board has rejected BASF’s improved takeover offer, saying it will not enter negotiations based on the information currently available. The proposal values Evonik at about €11 billion.
The company said it remains focused on developing Evonik as an independent business. It is willing to hear BASF’s reasons for the offer in a confidential, informational exchange.
BASF’s letter dated Oct. 22 expressed interest in making a voluntary public takeover offer, Evonik said. As of Friday at 16:39 UTC, Evonik shares traded at €21.04, up 0.1%, while BASF shares were at €53.46, up 0.24%.
This article was produced with the help of AI technology. Based on reporting by the outlets listed above.